IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kazia Therapeutics LTD

CUSIP: 48669G204 | 16 institutional holders

Quarters

Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2025

Barclays PLC120,000
0.0% of portfolio›$93.9K
UBS Group AG26,285
0.0% of portfolio›$20.6K
MAI Capital Management3,854
0.0% of portfolio›$3.0K
Rhumbline Advisers1,911
0.0% of portfolio›$1.5K
Gamma Investing LLC1,327
0.0% of portfolio›$1.0K
Arax Advisory Partners1,000
0.0% of portfolio›$783
Osaic Holdings, Inc.50
0.0% of portfolio›$39
Simplex Trading, LLC5
0.0% of portfolio›$0
Wells Fargo & Company4
0.0% of portfolio›$3
Allworth Financial LP1
0.0% of portfolio›$4
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Barclays PLC
120,000$93.9K0.0%GrowthMediumLondon, United Kingdom2026-03-17
UBS Group AG
26,285$20.6K0.0%CoreMediumZurich, Switzerland2025-05-13
MAI Capital Management
3,854$3.0K0.0%IndexVery LowIndependence, OH2025-05-15
Rhumbline Advisers
1,911$1.5K0.0%IndexVery LowBoston, MA2025-05-29
Gamma Investing LLC
1,327$1.0K0.0%IndexVery LowFoster City, CA2025-04-15
Arax Advisory Partners
1,000$7830.0%CoreHighNew York, NY2025-05-15
Osaic Holdings, Inc.
50$390.0%IndexLowScottsdale, AZ2025-05-12
Simplex Trading, LLC
5$00.0%GARPVery HighChicago, IL2025-05-12
Wells Fargo & Company
4$30.0%CoreLowSan Francisco, CA2025-05-13
Allworth Financial LP
1$40.0%ETFLowFolsom, CA2025-04-30
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2025-05-14